Building a network of ADPKD Reference Centres across Europe: The EuroCYST Initiative

Istanbul Berlin Prague Erlangen Zurich Bergamo Freiburg Brussels Groningen Sheffield Cambridge Barcelona Toulouse Brest

To build a cohort for a longitudinal observational study, 14 centres in 10 countries across Europe will enroll 1.100 adult ADPKD patients until the end of 2015. The study is funded by a grant of the ERA – EDTA with 1 million Euros.

  • University Hospital Zurich, Zurich, Switzerland,
    PD Dr. Andreas Serra
  • University Hospital Erlangen, Erlangen, Germany
    Prof. Dr. Kai-Uwe Eckardt
  • University Hospital Freiburg, Freiburg, Germany
    Prof. Dr. Gerhard Walz, PD Dr. Anna Köttgen
  • University Medical Center Groningen, Groningen, Netherlands, Dr. Ron Gansevoort
  • University of Sheffield Medical School Academic Unit of Nephrology, Department of Infection and Immunity, Sheffield, United Kingdom, Prof. Dr. Albert Ong
  • Cliniques Universitaires Saint-Luc, Bruxelles, Belgium Prof. Dr. Yves Pirson
  • IRCCS – Istituto di Ricerche Farmacologiche Mario Negri Bergamo, Italy and Unit of Nephrology, Dialysis and Transplantation, A.O. Papa Giovanni XXIII, Bergamo, Italy, Prof. Dr. Giuseppe Remuzzi, Dr. Norberto Perico
  • University of Cambridge, Cambridge, United Kingdom Prof. Dr. Richard Sandford
  • Charles University Prague, Prague, Czech Republic
    Prof. Dr. Vladimir Tesar
  • Istanbul School of Medicine, Istanbul, Turkey
    Prof. Dr. Süleyman Tevfik Ecder
  • Hôpital de Rangueil, Toulouse, France
    Prof. Dr. Dominique Chaveau
  • Fundació Puigvert, Barcelona, Spain
    Dr. Roser Torra
  • Charité Universitätsmedizin Berlin, Berlin, Germany
    Prof. Dr. Klemens Budde
  • Centre hospitalier universitaire de Brest, Brest, France
    Prof. Dr. Yannick Le Meur